It seems CRSP will follow MRNA and the biotech narrative.
According to the technical output, price looks to be developing an LPS, on the D phase, volume decreasing, textbook.
According to the technical output, price looks to be developing an LPS, on the D phase, volume decreasing, textbook.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.